-
<![CDATA[Pumitamig Shows Positive Trend in PFS Treating Patients With ES-SCLC]]>
26 Sep 2025 20:11 GMT
… Study of Lung Cancer 2025 World Conference on Lung Cancer in Barcelona … levels of pumitamig plus paclitaxel or topotecan in … With Small-cell Lung Cancer in Combination With Chemotherapy … Study of Lung Cancer 2025 World Conference on Lung Cancer. Barcelona, …
-
<![CDATA[Multidisciplinary Team Discusses Practical Treatment Options in NSCLC ]]>
26 Sep 2025 19:19 GMT
… treatment of non–small cell lung cancer (NSCLC). Medical oncologists, … #47;carboplatin with paclitaxel or nab-paclitaxel for 4 cycles, … metastatic non-small cell lung cancer in the randomized … advanced non-small cell lung cancer. Clin Lung Cancer. 2022;23(5): …
-
Targeting Glucose Transporter 1 (GLUT1) in Cancer: Molecular Mechanisms and Nanomedicine Applications
25 Sep 2025 14:07 GMT
… (Figure 2D).58 Paclitaxel was developed by functionalizing … glucose starvation therapy in lung cancer. Chembiochem. 2024;25 … -associated neutrophils promotes lung Cancer growth and resistance … glucose starvation therapy in lung cancer. Chembiochem. 2024;25 …
-
Immuneering Asset Nearly Doubles Overall Survival in Pancreatic Cancer After 9 Months
25 Sep 2025 14:24 GMT
… plus chemotherapies gemcitabine/nab-paclitaxel as a first-line therapy … , including in non-small cell lung cancer.
-
Clinical Management of Circulating Tumor DNA in Breast Cancer: Detection, Prediction, and Monitoring
25 Sep 2025 14:07 GMT
… cancers like non-small cell lung cancer, which was 91.1%.37 … study, TBCRC 030, evaluating neoadjuvant paclitaxel plus cisplatin and residual cancer …
-
Why Immuneering Stock Soared Over 40% After-Hours Today
25 Sep 2025 06:13 GMT
… with modified gemcitabine/nab-paclitaxel showed an 86% overall survival … , including in non-small cell lung cancer.
Progression-free survival at nine …
-
Enhertu plus pertuzumab granted Priority Review in US as 1st-line treatment for patients with HER2-positive metastatic breast cancer
25 Sep 2025 03:31 GMT
… THP (a taxane [docetaxel or paclitaxel], trastuzumab and pertuzumab) as a … or metastatic non-small cell lung cancer (NSCLC) whose tumours have activating …
-
Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP
24 Sep 2025 20:01 GMT
… modified gemcitabine/nab-paclitaxel (mGnP) in first-line … , gemcitabine/nab-paclitaxel, reported significantly lower OS … in non-small cell lung cancer
About Immuneering
Immuneering is … in non-small cell lung cancer. These forward-looking statements …
-
Intas Pharma Told to Revise Phase I, III Pembrolizumab Trial Protocol
24 Sep 2025 19:10 GMT
… Non-squamous Non Small Cell Lung Cancer” vide Protocol No. 0142-25 … metastatic melanoma, non-small-cell lung cancer, cervical cancer, head and neck … narrowed.
3. The dose of Paclitaxel should be reduced
4. Study …
-
Engineering Study on Targeted Therapy of Osteosarcoma Using Tripterine Loaded Polydopamine Mesoporous Microspheres Combined with Photothermal Therapy
24 Sep 2025 09:50 GMT
… glioma, leukemia, melanoma, pancreatic cancer, lung cancer, prostate cancer, breast cancer, and … . Multifunctional mesoporous polydopamine with hydrophobic paclitaxel for photoacoustic imaging-guided chemo …
About
© 1995-2025